ATE430585T1 - Zusammensetzung zur oralen oder rektalen verabreichung - Google Patents
Zusammensetzung zur oralen oder rektalen verabreichungInfo
- Publication number
- ATE430585T1 ATE430585T1 AT03703650T AT03703650T ATE430585T1 AT E430585 T1 ATE430585 T1 AT E430585T1 AT 03703650 T AT03703650 T AT 03703650T AT 03703650 T AT03703650 T AT 03703650T AT E430585 T1 ATE430585 T1 AT E430585T1
- Authority
- AT
- Austria
- Prior art keywords
- composition
- suppository
- tablet
- oral
- food supplement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0200475A SE0200475D0 (sv) | 2002-02-15 | 2002-02-15 | Oral farmaceutisk beredning |
PCT/SE2003/000251 WO2003068267A1 (en) | 2002-02-15 | 2003-02-14 | Composition for oral or rectal administration |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE430585T1 true ATE430585T1 (de) | 2009-05-15 |
Family
ID=20286999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03703650T ATE430585T1 (de) | 2002-02-15 | 2003-02-14 | Zusammensetzung zur oralen oder rektalen verabreichung |
Country Status (20)
Country | Link |
---|---|
US (1) | US20050181042A1 (de) |
EP (1) | EP1474174B1 (de) |
JP (1) | JP2005520816A (de) |
KR (1) | KR20040089633A (de) |
CN (1) | CN101060862A (de) |
AT (1) | ATE430585T1 (de) |
AU (1) | AU2003206355B2 (de) |
BR (1) | BR0313651A2 (de) |
CA (1) | CA2475025C (de) |
DE (1) | DE60327511D1 (de) |
DK (1) | DK1474174T3 (de) |
ES (1) | ES2324603T3 (de) |
MX (1) | MXPA04007946A (de) |
NZ (1) | NZ534812A (de) |
PT (1) | PT1474174E (de) |
RU (1) | RU2302260C2 (de) |
SE (1) | SE0200475D0 (de) |
SI (1) | SI1474174T1 (de) |
WO (1) | WO2003068267A1 (de) |
ZA (1) | ZA200406399B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0201922D0 (sv) * | 2002-06-20 | 2002-06-20 | Ltp Lipid Technologies Provide | Koagulationshindrande komposition (Anticoagulant Composition) |
SE0400233D0 (sv) * | 2004-02-04 | 2004-02-04 | Ltp Lipid Technologies Provide | Rektal komposition |
WO2006115463A1 (en) * | 2005-04-28 | 2006-11-02 | Galenica Technology Ab | Pharmaceutical dosage forms comprising a lipid phase |
WO2007098446A2 (en) * | 2006-02-21 | 2007-08-30 | Accu-Break Pharmaceuticals, Inc. | Method for minimizing variation in dosage forms |
CN101278928B (zh) | 2007-04-06 | 2011-09-07 | 常州高新技术产业开发区三维工业技术研究所有限公司 | 含左卡尼汀或其衍生物的药物组合物及其用途 |
CN101991557B (zh) * | 2009-08-10 | 2013-09-18 | 杭州赛利药物研究所有限公司 | 一种盐酸万古霉素液体胶囊及其制备方法 |
US20140044779A1 (en) * | 2011-04-18 | 2014-02-13 | Lipidor Ab | Liquid Carrier for Oral Delivery of a Pharmacologically Active Agent |
US10117885B2 (en) * | 2011-08-11 | 2018-11-06 | Allergy Research Group, Llc | Chewable lipid supplements for treating pain and fibromyalgia |
CN102631290A (zh) * | 2012-04-05 | 2012-08-15 | 韩昌志 | 一种生产栓剂的综合法 |
US10456327B2 (en) | 2015-08-28 | 2019-10-29 | Craig Robertson | Package for frozen nutrient pill |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7812466A (nl) * | 1978-12-22 | 1980-06-24 | Shell Int Research | Werkwijze voor de bereiding van gasmengsels. |
DE2951142C2 (de) * | 1979-12-19 | 1983-11-03 | A. Nattermann & Cie GmbH, 5000 Köln | Suppositorium-Zubereitung von Indometacin oder Acemetacin |
US4966776A (en) * | 1983-04-11 | 1990-10-30 | Board Of Regents, The University Of Texas System | Compositions and methods of treating calcium renal stones |
US4699776A (en) * | 1985-06-28 | 1987-10-13 | R. P. Scherer Corporation | Suppositories containing analgesics, antipyretics or anti-inflammatory agents |
US5082667A (en) * | 1988-06-07 | 1992-01-21 | Abbott Laboratories | Solid pharmaceutical dosage in tablet triturate form and method of producing same |
AU645003B2 (en) * | 1988-11-08 | 1994-01-06 | Takeda Chemical Industries Ltd. | Sustained release preparations |
JP2893191B2 (ja) * | 1988-11-08 | 1999-05-17 | 武田薬品工業株式会社 | 放出制御性マトリックス剤 |
SE9003100D0 (sv) * | 1990-09-28 | 1990-09-28 | Kabivitrum Ab | Lipid formulation system |
JPH08510989A (ja) * | 1992-10-16 | 1996-11-19 | グラクソ、グループ、リミテッド | ラニチジン組成物 |
US5505982A (en) * | 1994-01-28 | 1996-04-09 | Fmc Corporation | Chocolate confection |
CN1091591C (zh) * | 1994-02-04 | 2002-10-02 | 利珀克尔集团公司 | 亲脂载体制剂 |
JP2948111B2 (ja) * | 1994-09-16 | 1999-09-13 | 塩野義製薬株式会社 | 経口投与用油性組成物 |
DE29511421U1 (de) * | 1995-07-14 | 1995-10-12 | Chou, Wen San, An Ting, Tainan | Luftkompressor |
IL117773A (en) * | 1996-04-02 | 2000-10-31 | Pharmos Ltd | Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability |
ID21009A (id) * | 1997-10-08 | 1999-04-08 | Taisho Pharmaceutical Co Ltd | Komposisi untuk supositori |
GB9724544D0 (en) * | 1997-11-21 | 1998-01-21 | Smithkline Beecham Plc | Novel Formulation |
FR2775188B1 (fr) * | 1998-02-23 | 2001-03-09 | Lipha | Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption |
SE9804192D0 (sv) * | 1998-12-03 | 1998-12-03 | Scotia Lipidteknik Ab | New formulation |
EP1043016B1 (de) * | 1999-03-30 | 2014-08-20 | Sodic Sa | Pflanzenextrakt auf Glycerid-, Phospholipid- und Phytosphingolipidbasis, Verfahren für die Gewinnung dieses Extrakts und ihn enthaltende kosmetische Zusammensetzungen |
US7208180B2 (en) * | 2000-05-08 | 2007-04-24 | N.V. Nutricia | Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith |
JP4116436B2 (ja) * | 2000-12-14 | 2008-07-09 | エフ.ホフマン−ラ ロシュ アーゲー | 自己乳化脂質マトリックス(selm) |
-
2002
- 2002-02-15 SE SE0200475A patent/SE0200475D0/xx unknown
-
2003
- 2003-02-14 DK DK03703650T patent/DK1474174T3/da active
- 2003-02-14 DE DE60327511T patent/DE60327511D1/de not_active Expired - Lifetime
- 2003-02-14 CA CA2475025A patent/CA2475025C/en not_active Expired - Fee Related
- 2003-02-14 AU AU2003206355A patent/AU2003206355B2/en not_active Ceased
- 2003-02-14 JP JP2003567447A patent/JP2005520816A/ja active Pending
- 2003-02-14 US US10/504,490 patent/US20050181042A1/en not_active Abandoned
- 2003-02-14 KR KR10-2004-7012595A patent/KR20040089633A/ko not_active Application Discontinuation
- 2003-02-14 ES ES03703650T patent/ES2324603T3/es not_active Expired - Lifetime
- 2003-02-14 NZ NZ534812A patent/NZ534812A/en not_active IP Right Cessation
- 2003-02-14 AT AT03703650T patent/ATE430585T1/de active
- 2003-02-14 BR BRPI0313651-5A patent/BR0313651A2/pt not_active IP Right Cessation
- 2003-02-14 EP EP03703650A patent/EP1474174B1/de not_active Expired - Lifetime
- 2003-02-14 MX MXPA04007946A patent/MXPA04007946A/es active IP Right Grant
- 2003-02-14 CN CNA038040131A patent/CN101060862A/zh active Pending
- 2003-02-14 RU RU2004124042/15A patent/RU2302260C2/ru not_active IP Right Cessation
- 2003-02-14 SI SI200331606T patent/SI1474174T1/sl unknown
- 2003-02-14 PT PT03703650T patent/PT1474174E/pt unknown
- 2003-02-14 WO PCT/SE2003/000251 patent/WO2003068267A1/en active IP Right Grant
-
2004
- 2004-08-12 ZA ZA200406399A patent/ZA200406399B/en unknown
Also Published As
Publication number | Publication date |
---|---|
SI1474174T1 (sl) | 2009-08-31 |
CN101060862A (zh) | 2007-10-24 |
PT1474174E (pt) | 2009-06-25 |
JP2005520816A (ja) | 2005-07-14 |
CA2475025C (en) | 2010-07-27 |
ES2324603T3 (es) | 2009-08-11 |
NZ534812A (en) | 2006-10-27 |
CA2475025A1 (en) | 2003-08-21 |
WO2003068267A1 (en) | 2003-08-21 |
DE60327511D1 (de) | 2009-06-18 |
DK1474174T3 (da) | 2009-07-06 |
BR0313651A2 (pt) | 2008-11-11 |
AU2003206355B2 (en) | 2007-03-01 |
EP1474174B1 (de) | 2009-05-06 |
AU2003206355A1 (en) | 2003-09-04 |
MXPA04007946A (es) | 2005-06-08 |
EP1474174A1 (de) | 2004-11-10 |
SE0200475D0 (sv) | 2002-02-15 |
RU2302260C2 (ru) | 2007-07-10 |
ZA200406399B (en) | 2005-09-12 |
KR20040089633A (ko) | 2004-10-21 |
RU2004124042A (ru) | 2005-06-10 |
US20050181042A1 (en) | 2005-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ596244A (en) | Treatment of neurodegenerative diseases | |
DE60302348D1 (de) | Verwendung von cyclopamine zur behandlung von psoriasis und anderen hauterkrankungen | |
FIC20130042I1 (fi) | Fampridiini tai sen suola tai solvaatti | |
ECSP055844A (es) | Nuevos compuestos triciclicos | |
ATE228015T1 (de) | Intestinale absorption von nikotin für die behandlung von nikotinabhängigen zustanden | |
ZA200600579B (en) | Piperazine derivatives and methods of use | |
MXPA05010958A (es) | Derivados indazol como inhibidores jnk. | |
MXPA01008058A (es) | Composiciones deinhibidor de cicloxigenasa-2 teniendo un rapido inicio de efecto terapeutico. | |
AR060019A1 (es) | Composicion farmaceutica, producto y metodo de tratamiento para un trastorno cognitivo y usos de un inhibidor de acetilcolinesterasa y un antagonista de 5- ht6 en la fabricacion de un medicamento para el tratamiento de un trastorno cognitivo | |
ATE430585T1 (de) | Zusammensetzung zur oralen oder rektalen verabreichung | |
EE05423B1 (et) | IL-18 inhibiitori kasutamine maksakahjustuse ja muude haiguste raviks v?i ennetamiseks sobiva ravimi valmistamiseks, vektori ja raku kasutamine inhibiitori produtseerimisel ning IL-18 inhibiitorit sisaldav farmatseutiline kompositsioon | |
WO2003106450A8 (de) | Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren | |
CA2190847A1 (en) | Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases | |
EP1178796A4 (de) | Aminoimidazolcarboxamidesalze zur vorbeugung und behandlung von leberkrankheiten | |
IL163951A0 (en) | New heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in medicine | |
PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
MY140954A (en) | Composition for oral or rectal administration | |
DE60309465D1 (de) | Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen | |
PL324012A1 (en) | N-hydroxyureas as antiinflammatory agents | |
ATE369865T1 (de) | Gerinnungshemmende zusammensetzung | |
UA66932C2 (en) | Complex of eletriptan and sulphobutylether-beta-cyclodextrin, pharmaceutical composition, method for their manufacture and method for treating migraine | |
ATE355287T1 (de) | 2-oxo-1,3,4-trihydrochinazolin derivative zur behandlung von zellproliferationskrankheiten | |
PL375354A1 (en) | Use of treosulfan and derivatives thereof for treating multiple sclerosis | |
FI20031793A0 (fi) | Uusi anti-proliferatiivinen farmaseuttinen koostumus | |
UA3173U (uk) | Спосіб лікування первинної відкритокутової глаукоми |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1474174 Country of ref document: EP |